Therefore, these data suggest a novel inter-relationship between these immune markers in colon cancers whereby the prognostic impact of FoxP3+ T cells is enhanced in a background of low cytotoxic CD8+ cells. The gene discussed is CD8A; the disease is colonic neoplasm.